Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Common Equity (2022 - 2025)

ASP Isotopes has reported Common Equity over the past 4 years, most recently at $204.2 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 326.21% to $204.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $204.2 million, a 326.21% increase, with the full-year FY2025 number at $204.2 million, up 326.21% from a year prior.
  • Common Equity reached $204.2 million in Q4 2025 per ASPI's latest filing, up from $96.6 million in the prior quarter.
  • The five-year high for Common Equity was $204.2 million in Q4 2025, with the low at $6.3 million in Q3 2022.
  • The 4-year median for Common Equity is $13.7 million (2024), against an average of $35.8 million.
  • The largest YoY upside for Common Equity was 386.27% in 2024 against a maximum downside of 9.36% in 2024.
  • Tracing ASPI's Common Equity over 4 years: stood at $9.8 million in 2022, then surged by 91.81% to $18.8 million in 2023, then skyrocketed by 154.36% to $47.9 million in 2024, then skyrocketed by 326.21% to $204.2 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $204.2 million, $96.6 million, and $28.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.